| Wednesday, October 28, 2026 | |||
|---|---|---|---|
| 6:30 PM - 6:35 PM | Introduction to MASLD Guidance | Keyur Patel, UHN Toronto |  |
| 6:35 PM - 6:40 PM | Nomenclature | Michael Betel, Fatty Liver Alliance |  |
| 6:40 PM - 6:55 PM | Epidemiology and Natural History | Giada Sebastiani, McGill University Health Centre |  |
| 6:55 PM - 7:10 PM | Screening & Risk Stratification of MASLD Patients in Clinical Practice | Mark Swain, Calgary |  |
| 7:10 PM - 7:25 PM | Management | Alnoor Ramji, UBC |  |
| 7:25 PM - 7:40 PM | Unmet needs/future/Summary points and Guidance Statement | Keyur Patel, UHN Toronto Mohit Kehar, University of Ottawa | |
| 7:40 PM - 8:00 PM | Q&A / Panel Discussion | ||
Time Zone: (UTC-04:00) Eastern Time (US & Canada) [Change Time Zone]